Identification of CD19 as a shared biomarker via PPARγ/β-catenin/Wnt3a pathway linking psoriasis and major depressive disorder

Bin Zhou, Ting Wu, Haitao Li, Jiahao Yang, Zhujun Ma, Yunli Ling, Hanying Ma, Changzheng HuangJournal of Affective Disorders 2024 · DOI

Abstract

CD19 may serve as a common biomarker or therapeutic target of psoriasis and MDD via PPARγ/β-catenin/Wnt3a pathway.
BibTeX
@article{zhou2024identification,
  author = {Bin Zhou and Ting Wu and Haitao Li and Jiahao Yang and Zhujun Ma and Yunli Ling and Hanying Ma and Changzheng Huang},
  title = {{Identification of CD19 as a shared biomarker via PPARγ/β-catenin/Wnt3a pathway linking psoriasis and major depressive disorder}},
  journal = {Journal of Affective Disorders},
  year = {2024},
  doi = {10.1016/j.jad.2024.08.159},
}

Loading related content...

Figure